ResMed reported $6.68B in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Ansell ANN:AU USD 2.56B 53.1M
Cochlear COH:AU AUD 2.47B 1.6M
CSL CSL:AU USD 35.45B 7.1B
Estia Health EHE:AU AUD 1.87B 79.36M
Fisher & Paykel Healthcare FPH:AU NZD 2.09B 12.5M
Healius Ltd HLS:AU AUD 4.06B 77.3M
Integral Diagnostics Ltd IDX:AU AUD 839.19M 56.18M
Mayne Pharma MYX:AU AUD 1.49B 205.66M
Nanosonics Ltd NAN:AU AUD 201.46M 13.79M
Opthea Ltd OPT:AU USD 154.01M 93.96M
Polynovo Ltd PNV:AU AUD 89.24M 54.26M
Ramsay Health Care RHC:AU AUD 20.36B 862.1M
Regis Healthcare REG:AU AUD 1.72B 4.78M
ResMed RMD:AU USD 6.68B 1.58B
Sigma Healthcare Ltd SIG:AU AUD 1.18B 71.34M
Sonic Healthcare SHL:AU AUD 12.54B 15.6M
Telix Pharmaceuticals Ltd TLX:AU AUD 255.35M 39.41M